(photo credit: )
Tel Aviv University has licensed an Alzheimer's treatment it developed to Merz Pharmaceuticals, a German producer of Alzheimer's drugs.
Ramot, Tel Aviv University's technology transfer company, raised $8.5 million for research into the treatment in 2003.
Merz is the developer of Memantine, an anti-dementia drug, as well as treatments for Parkinson's Disease and depression.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>